Literature DB >> 36047535

Preparation and Characterization of Chitosan and Inclusive Compound-Layered Gold Nanocarrier to Improve the Antiproliferation Effect of Tamoxifen Citrate in Colorectal Adenocarcinoma (Caco-2) and Breast Cancer (MCF-7) Cells.

Yahia Kahlous1, Vijayaraj Kumar Palanirajan1, Melbha Starlin1, Jeetendra Singh Negi1, Shiau-Chuen Cheah2.   

Abstract

Objectives: Cancer diseases have been linked to a huge number of causes that led to deaths in this century along with cardiovascular and lung diseases. Most death-leading types of cancer are colon, lung, breast, and prostate cancers. Due to the remarkable properties of gold (Au) nanocarrier, they are used to deliver and improve tamoxifen (Tam) citrate activity in Caco-2 and MCF-7 cells. Materials and
Methods: In this study, preparation of Au nanoparticles (NPs), zeta-potential and size, high resolution transient electron microscopy (HRTEM), high-performance liquid chromatography, ultraviolet-visible spectra, fluorescence microscopy, fourier infrared spectroscopy, and real-time cellular analysis xCELLigence technology were investigated.
Results: The zeta-average size of the Tam- β-cyclodextrin (β-CD)-hyaluronic acid (HA)-chitosan (Chi)-Au nanocomposite is 82.02 nm with a negative zeta potential of -23.6. Furthermore, HRTEM images showed that, successful formulation of polymer shell around Au core and the Au NP shape is mostly spherical, triangle and irregular. Furthermore, the fluorescence microscope image showed proper cellular uptake of the Tam-β-CD-HA-Chi-Au nanocomposite in MCF-7 and Caco-2 cells. Additionally, Tam-β-CD-HA-Chi-Au nanocomposite significantly improved the cytotoxic activity of Tam citrate on Caco-2 cells. IC50 value of Tam reduced from 8.55 µM to 5.32 µM, after 48 h of incubation time (p value <0.00001).
Conclusion: This study showed that Tam-β-CD-HA-Chi-Au nanocomposite is a potential nanocarrier for delivering the drug to Caco-2 and MCF-7 cancer cells, since it has improved Tam citrate activity on colorectal cancer cells. After all, the developed formula showed more effect on Caco-2 than MCF-7. The prepared nanocomposite could be used to improve the cancer therapy in clinical trials.

Entities:  

Keywords:  Chitosan gold nanoparticles; MCF-7 cell line and Caco-2 cell line; Xcelligence RTCA systems; cytotoxicity and cellular uptake; tamoxifen citrate and β-cyclodextrin

Year:  2022        PMID: 36047535      PMCID: PMC9438755          DOI: 10.4274/tjps.galenos.2021.48961

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  32 in total

1.  Chitosan nanoparticles: preparation, size evolution and stability.

Authors:  Antonio Rampino; Massimiliano Borgogna; Paolo Blasi; Barbara Bellich; Attilio Cesàro
Journal:  Int J Pharm       Date:  2013-07-22       Impact factor: 5.875

Review 2.  Pharmaceutical applications of chitosan.

Authors:  Zahra Shariatinia
Journal:  Adv Colloid Interface Sci       Date:  2018-11-30       Impact factor: 12.984

Review 3.  Recent advances in endocrine therapy of breast cancer.

Authors:  A Howell; M Dowsett
Journal:  BMJ       Date:  1997-10-04

Review 4.  Chitosan and chitosan coating nanoparticles for the treatment of brain disease.

Authors:  Shuangwen Yu; Xiaolu Xu; Jianfang Feng; Mei Liu; Kaili Hu
Journal:  Int J Pharm       Date:  2019-02-14       Impact factor: 5.875

Review 5.  Chemopreventive effects of some popular phytochemicals on human colon cancer: a review.

Authors:  Yueliang Zhao; Xiaoqian Hu; Xinyuan Zuo; Mingfu Wang
Journal:  Food Funct       Date:  2018-09-19       Impact factor: 5.396

6.  Gold nanoparticles: a revival in precious metal administration to patients.

Authors:  A S Thakor; J Jokerst; C Zavaleta; T F Massoud; S S Gambhir
Journal:  Nano Lett       Date:  2011-09-07       Impact factor: 11.189

Review 7.  Doxil®--the first FDA-approved nano-drug: lessons learned.

Authors:  Yechezkel Barenholz
Journal:  J Control Release       Date:  2012-03-29       Impact factor: 9.776

Review 8.  Nanodrug delivery systems for targeting the endogenous tumor microenvironment and simultaneously overcoming multidrug resistance properties.

Authors:  Rui Li; Yan Xie
Journal:  J Control Release       Date:  2017-02-21       Impact factor: 9.776

Review 9.  Immune system targeting by biodegradable nanoparticles for cancer vaccines.

Authors:  Joana M Silva; Mafalda Videira; Rogério Gaspar; Véronique Préat; Helena F Florindo
Journal:  J Control Release       Date:  2013-03-21       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.